Ultragenyx Pharmaceutical Inc
F:UP0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
Ultragenyx Pharmaceutical Inc
F:UP0
|
US |
|
G
|
Genesco Inc
F:GN8
|
US |
|
C
|
Commerce Bancshares Inc
XMUN:CB5
|
US |
|
Sveafastigheter publ AB
F:008
|
SE |
|
R
|
Royal Gold Inc
F:RG3
|
US |
|
M
|
MAX Automation SE
F:MXHN
|
DE |
|
Erdene Resource Development Corp
F:E8K
|
CA |
|
Helia Group Ltd
F:0GI0
|
AU |
|
H
|
Hologic Inc
XMUN:HO1
|
US |
|
F
|
Future Consumer Ltd
BSE:533400
|
IN |
|
Oportun Financial Corp
NASDAQ:OPRT
|
US |
|
M
|
Max Financial Services Ltd
BSE:500271
|
IN |
|
VNET Group Inc
F:217A
|
CN |
|
C
|
Companhia Energetica de Minas Gerais CEMIG
F:CID
|
BR |
|
WH Group Ltd
F:0WH
|
HK |
|
V
|
VNET Group Inc
DUS:217A
|
CN |
|
ARE Holdings Inc
F:A19
|
JP |
Shareholder Yield
Current shareholder yield for 
UP0 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
UP0 Price
Ultragenyx Pharmaceutical Inc
| Average Annual Return | -13.33% |
| Standard Deviation of Annual Returns | 19.1% |
| Max Drawdown | -82% |
| Market Capitalization | 2.8B EUR |
| Shares Outstanding | 90 569 200 |
| Percentage of Shares Shorted |
N/A
|
